Karnataka cops launch probe into Kasaragod girl’s rape allegation after Shobha’s intervention

News Network
January 6, 2020

Bengaluru, Jan 6: The city police commissioner Bhaskar Rao has ordered a special inquiry by the additional commissioner in connection with sexual harassment on a girl hailing from Kasaragod and the allegation that there were attempts to convert her to another religion.

Udupi-Chikmagalur MP Shobha Karandlaje on Sunday met Rao along with the girl and gave a complaint that two youths from Kasargod had raped her and forced her to convert to their religion.

A complaint has been filed in the Kasargod police station, but no action has been taken against them. Since both the accused work in Electronics City police station jurisdiction, she urged the police to arrest them.

Rao said he was yet to gather information about the case and he had directed the additional commissioner to conduct a preliminary investigation and submit a report.

After filing a complaint, Shobha told reporters that she has been sexually harassed ever since she was a minor. 

The MP said that the girl, who was brought from Kasaragod to Electronics City, where the accused youths run a business, was allegedly raped. “I have asked the Police Commissioner to direct the Electronics City police to register an FIR and arrest the youths,” she said.

“I have spoken to the survivor and she said that the youths were also forcing her to convert to Islam and threatened her with dire consequences if she did not,” the MP alleged.

Shobha went on to claim that there was a gang that could be operating to forcibly convert Hindu women to Islam. She also met Chief Minister B S Yediyurappa along with the girl’s family members and gave a petition.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 15,2020

Bengaluru, July 15: The family members of a 67-year-old man, who had developed some symptoms of Covid-19, was in for a rude shock when a “reputed” private hospital in Bengaluru’s Whitefield quoted estimated bill of Rs 9.09 lakh for 10 days.

The elderly man was rushed to Columbia Asia Hospital even before receiving his covid-19 test report. But after a look at the estimated bill, the family chose not to admit him there.

The break-up of the estimated bill included Rs 1.40 lakh for ventilator, Rs 3 lakh for medicines, medical supplies and consumables, Rs 2 lakh for laboratory investigations, Rs 75,000 for room rent, Rs 75,000 towards professional fee, Rs 58,500 for nursing charges, Rs 35,000 for radiology investigations and physiotherapy, and Rs 25,000 for equipment and surgical items.

The hospital authorities reportedly told the family members that the actual bill could be higher in the event of complications, unanticipated extension of stay and comorbidities.

“He was tested on Sunday and we were waiting for the result. On Monday, he started gasping for breath. Columbia Asia Hospital told us they had an ICU bed and we rushed him to the emergency care. When they showed us the estimate, we were shocked,” said Abdul Bashir, a nephew of the patient.

“We then contacted Dr Taha Mateen of HBS Hospital through an NGO ‘Mercy Mission’. We got him admitted there for just Rs 25,000,” he said adding that Hospitals should not take advantage when emotions are running high. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 13,2020

New Delhi, Feb 13: Two SpiceJet pilots have been suspended today for an improper landing at Mangalore Airport which damaged three runway edge lights. The incident took place on October 31 last year when the private carrier's Boeing 737 aircraft was returning from Dubai.

The Directorate General of Civil Aviation (DGCA) suspended the licenses of the pilots for four-and-half months from the date of the incident.

DGCA had issued a show cause notice to the Pilot in Command and the First Officer demanding explanation of the "lapses" and found their replies unsatisfactory, the aviation watchdog said in a statement.

Investigation revealed that the touchdown was improper as it deviated to the the left on the runway in turn damaging three runway edge lights.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.